ARCHIVES

Phase III Trial Would Give Clearer Picture of C225 Role

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Charles Smart To Give Up Commission On Cancer Post, Kansas Surgeon To Become Fulltime Director

April 15, 1983

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

October 18, 2002

Committee Kills Pay Raise Bill; Rauscher Probably Will Resign

September 17, 1976

Sebelius: Congress Harming Nation’s Investment in Science

October 4, 2013

Britol-Meyers Holds Taxol Briefings, Outlines Timetable

July 5, 1991

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

July 26, 2002